-+ 0.00%
-+ 0.00%
-+ 0.00%

Star Sports Medicine plans repurchase of up to 2.9 million H shares under buyback mandate

PUBT·08/18/2026 09:19:59
Listen to the news
Star Sports Medicine plans repurchase of up to 2.9 million H shares under buyback mandate
  • Star Sports Medicine set an H-share buyback of up to 2,900,000 shares, about 5.29% of outstanding H shares.
  • Authorization stems from the June 26, 2026 annual shareholders’ meeting mandate covering up to 5,483,134 H shares, or 10%.
  • Repurchases may be executed in the open market, with price capped at 105% of the prior five-day average closing price.
  • Buyback shares will be held as treasury stock, funded from internal resources, for potential resale or equity incentive use.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Star Sports Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260818-12288613), on August 18, 2026, and is solely responsible for the information contained therein.